Resistance Analyses of Japanese Hepatitis C-Infected Patients Receiving Sofosbuvir or Ledipasvir/Sofosbuvir Containing Regimens in Phase 3 Studies-Reference-Cited by-同舟云学术

Resistance Analyses of Japanese Hepatitis C-Infected Patients Receiving Sofosbuvir or Ledipasvir/Sofosbuvir Containing Regimens in Phase 3 Studies

Published:2016-05-15 Issue:10 Volume:23 Page:780-788
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Mizokami M.¹,Dvory-Sobol H.²,Izumi N.³,Nishiguchi S.⁴,Doehle B.²,Svarovskaia E. S.²,De-Oertel S.²,Knox S.²,Brainard D. M.²,Miller M. D.²,Mo H.²,Sakamoto N.⁵,Takehara T.⁶,Omata M.⁷

Affiliation:

1. The Research Center for Hepatitis & Immunology; National Center for Global Health and Medicine; Chiba Japan

2. Gilead Sciences Inc.; Foster City CA USA

3. Musashino Red Cross Hospital; Tokyo Japan

4. Hyogo College of Medicine; Hyogo Japan

5. Hokkaido University; Hokkaido Japan

6. Osaka University; Osaka Japan

7. Yamanashi Prefectural Hospital Organization; Yamanashi Japan

Funder

Gilead Sciences

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12549/fullpdf

Reference30 articles.

1. Changing trends in hepatitis C infection over the past 50 years in Japan;Chung;Intervirology,2010

2. JSH Guidelines for the Management of Hepatitis C Virus Infection: a 2014 Update for Genotype 1.;Hepatology research: the official journal of the Japan Society of Hepatology,2014

3. Guidelines for the Management of Hepatitis C Virus Infection: first edition, May 2012;The Japan Society of Hepatology. Hepatology research: the official journal of the Japan Society of Hepatology,2013

4. New therapeutic strategies for hepatitis C;Di Bisceglie;Hepatology,2002

5. Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection;Asahina;Hepatology,2010

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Increase in the Prevalence of Clinically Relevant Resistance-Associated Substitutions in Four Direct-Acting Antiviral Regimens: A Study Using GenBank HCV Sequences;Pathogens;2024-08-09

2. World-wide Prevalence of Substitutions in HCV Genome Associated With Resistance to Direct-Acting Antiviral Agents;Clinical Gastroenterology and Hepatology;2021-09

3. Follow-Up of Patients Who Achieved Sustained Virologic Response after Interferon-Free Treatment against Hepatitis C Virus: Focus on Older Patients;Medicina;2021-07-27

4. Real‐world safety and effectiveness of ledipasvir/sofosbuvir for the treatment of chronic hepatitis C virus genotype 1 in Japan;Journal of Viral Hepatitis;2020-09-16

5. Viral and host factors are associated with retreatment failure in hepatitis C patients receiving all‐oral direct antiviral therapy;Hepatology Research;2020-04